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Objective: The concept of living with and beyond cancer is now emerging in policy
and literature. Rather than viewing this notion simply as a linear timeline, developing
an agreed understanding of the lived experience of people affected by cancer will aid
the development of person‐centred models of care.
Methods: A systematic review was conducted. The review question was “What
does the term ‘living with and beyond cancer’ mean to people affected by cancer?”
The protocol for the review was preregistered in the PROSPERO database (PROS-
PERO CRD42017059860). All included studies were qualitative, so narrative synthe-
sis was used to integrate descriptions and definitions of living with and beyond
cancer into an empirically based conceptual framework.
Results: Out of 2345 papers that were identified and 180 that were reviewed, a
total of 73 papers were included. The synthesis yielded three interlinked themes:
Adversity (realising cancer), Restoration (readjusting life with cancer), and Compatibil-
ity (reconciling cancer), resulting in the ARC framework.
Conclusions: Three themes describe the experience of living with and beyond can-
cer: adversity, restoration, and compatibility. The ARC framework provides an empir-
ically informed grounding for future research and practice in supportive cancer care
for this population.
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review1 | BACKGROUND
Around 2.5 million people are living with a cancer diagnosis in the
United Kingdom and more than half of those people receiving cancer
treatment will now live 10 years or more.1 While the concept of living- - - - - - - - - - - - - - - - - - - - - - - - - -
Creative Commons Attribution Li
by John Wiley & Sons Ltd.with and beyond cancer is evident in international policy and litera-
ture, supporting people to live with and beyond cancer is complex
because there are inconsistencies in understanding.2 For example,
living with and beyond cancer is commonly used to refer to the pro-
cess of coming to terms with, and overcoming, challenges associated- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
cense, which permits use, distribution and reproduction in any medium, provided
Psycho‐Oncology. 2019;28:948–959.
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people affected by cancer can lean towards a different meaning,
whereby living with and beyond cancer begins at diagnosis.4 The need
for clarity and an agreed understanding has therefore been identified
to better understand the experiences and needs of those who are
undergoing or have completed primary cancer treatment. This under-
standing can be used to develop person‐centred models of care and
improve the long‐term quality of life for people who live with and
beyond cancer.5
A conceptual framework addresses this need by providing a syn-
thesised understanding of living with and beyond cancer and to date,
no systematic review of evidence on conceptualising living with and
beyond (all types of) cancer (LWBC) has been undertaken. The aim
of this study was to identify and synthesise disparate accounts of
LWBC into a thorough, empirically based conceptual framework, with
a view to providing an empirical basis for future research and practice
in cancer care.6TABLE 1 Final search strategy
Search Terms (Free Text Terms)
Identified in the Title, Abstract, or
Keywords Concept
1 “cancer” All cancer (not diagnosis
specific)
2 (“life” OR “live” OR “lives” OR
“living”) adj (“with” OR
“beyond” OR “after”)
Living With and Beyond
3 “theor$” OR “framework” OR
“model” OR “dimension” OR
“paradigm” OR “concept$”
Understanding (truncated
terms
covering theory and
conceptualisation)
4 1 AND 2 AND 3
5 Limit to English Language
AND Remove duplicates2 | METHODS
The research aimed to draw together literature to explore the meaning
of LWBC. The protocol for the review was preregistered in the PROS-
PERO database (PROSPERO CRD42017059860).
2.1 | Eligibility criteria
The review sought to identify conceptual and empirical papers that
explicitly developed a conceptualisation of living with and beyond
any form of cancer. A conceptualisation of LWBC was defined as a
theory, model, or framework, which emerged from an analysis of pri-
mary data on at least three participants.7 Debates on sample size
and research quality continue; Pollio, Henley, and Thompson recom-
mend, “although not a formal methodological rule, the situational
diversity necessary for identifying thematic patterns is often provided
by three to five interview transcripts.”8(p51) The aim of this study was
to reflect the reality of participant accounts so a predefined under-
standing of LWBC was not used.
Studies were included if they
1. contained a conceptualisation of LWBC from which a succinct
summary could be extracted;
2. presented an original model or framework (based on primary
research) of LWBC;
3. presented primary research involving quantitative or qualitative
data based on at least three participants;
4. were available in printed or downloadable form; and
5. were available in English.
Exclusion criteria were as follows:
1. studies focusing solely on living with the consequences of treat-
ment, secondary symptoms, or dying;2. studies focusing on health‐related quality of life that used a
predefined definition; and
3. studies defining clinical remission criteria or recovery from cancer.
2.2 | Search strategy and data sources
Three search strategies were used to identify relevant papers: elec-
tronic database searching, hand searching, and web‐based searching.
2.2.1 | Electronic database searching
Six bibliographic databases were searched: EMBASE; Health Manage-
ment Information Consortium (HMIC); MEDLINE; PsycINFO; Scopus;
CINAHL. All databases were searched from 2000 to March week 2
2017 using search terms identified in the title, abstract, and keywords.
The search strategy was designed in OVID and modified for
EBSCOhost and Elsevier and is shown in Table 1.
Initial scoping searches were completed using three databases
(PsycINFO, Medline, and CINAHL) to narrow the key words and to
test medical subject heading (MeSH) terms. Due to the specificity of
the search (ie, patient experience and cancer as a disease), medical
subject headings were not used, and search terms were refined and
modified to optimise the balance between specificity and sensitivity.
Limits were also placed on the protocol to ensure feasibility. For
example, studies focusing on living with secondary symptoms or living
with dying were not included.
2.2.2 | Hand searching
The tables of contents of journals which publish key articles (British
Journal of Cancer, Psycho‐Oncology, and Cancer Nursing) were hand
searched (from 2000 to May 2017). These journals were chosen
because they were identified (eg, in database search) as having pub-
lished research specific to LWBC. While secondary research was
excluded from the review, existing systematic reviews9-16 and litera-
ture reviews17 of living with and beyond cancer were also hand
searched.
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An internet search using Google Scholar (scholar.google.co.uk) was
conducted using the search term “living with and beyond cancer” to
identify grey literature (ie, policy and practice guidance). The first
100 entries were reviewed. Specific cancer‐related and government
websites (ie, National Cancer Research Institute) and the Macmillan
Cancer Support internal evidence portal were also searched using
the search term “living with and beyond cancer.” Articles citing
included studies were searched using Web of Science (wok.mimas.
ac.uk).2.3 | Data extraction
Duplicates were removed in Endnote, Version 7.18 Titles identified in
the electronic search were screened, to identify those with possible
relevance. Abstracts from relevant publications were reviewed, and
where they appeared to meet the inclusion criteria, the full publication
was obtained and assessed for eligibility. Of the 2280 abstracts iden-
tified in the database search, a random 15% (n = 342) were indepen-
dently rated by authors C.L. and C.B. for eligibility.
One rater (C.L.) assessed the eligibility criteria for all 180 retrieved
papers, with a random subsample of 85 papers independently rated
for reliability by a second rater (C.B.). Acceptable concordance was
predefined as agreement on at least 90% of ratings. A concordance
of 92% was achieved. Reasons for exclusion were recorded, and dis-
agreements were resolved through discussion or by a third rater (S.
A.). For each included paper, the following data were extracted and
tabulated: methodological approach, participant information and inclu-
sion criteria, study location, and summary of main study findings.2.4 | Quality assessment
All included studies were qualitative, so quality was assessed using an
established framework for assessing qualitative research evidence.19
The quality assessment covers the various stages and processes within
qualitative enquiry, and the contribution, defensibility, rigour, and
credibility of the study. One rater (C.L.) assessed the quality of all
included studies, with a random 20% subsample of all papers
(n = 15) independently rated by a second rater (C.B.). Consensus
between raters was required, with differences in opinion on two of
the 15 papers resolved through discussion. Spencer et al19 clarify that
the quality framework is to be used as a heuristic guideline and so in
order to make judgements about the overall quality of papers a point
score was calculated using the quality framework.19 Each of the 18
items were weighted equally and rated “yes” (allocated 1 point) or
“no” (allocated 0 points), giving a maximum quality rating of 18. The
studies were divided into three groups; high quality was defined as a
score of 13 or more, medium‐quality papers scoring 7 to 12, and
low‐quality papers scoring 6 or less.
Quality assessment was not used to exclude papers given the
debate on whether quality checklists rate the quality of the study orthe quality of reporting.20 Instead, quality rating was used for sensitiv-
ity testing. For example, similarities and differences in results were
explored across high‐quality studies as well as across all studies (high‐,
medium‐, and low‐quality papers).2.5 | Data analysis
Narrative synthesis was used to synthesise the range and diversity of
the key concepts of living with and beyond cancer identified in
existing research. Narrative synthesis is an interpretive integration of
qualitative findings that are themselves an interpretive synthesis of
data. The narrative synthesis provides results that go beyond a
description of the primary studies and provide a new interpretation
and/or development of a new construct. This involves three stages:
developing a preliminary synthesis, exploring relationships between
studies and assessing the robustness of the synthesis.212.5.1 | Stage 1: developing a preliminary synthesis
To develop the preliminary synthesis, the main findings from each
included study were analysed using inductive thematic analysis. This
approach allows unexpected themes to emerge and does not restrict
the investigation to predetermined concepts or prejudge the signifi-
cance of concepts. One analyst (C.L.) extracted the data (themes
and theme descriptions) from each included study into Microsoft
Word tables. Analysis was then undertaken independently by two
authors (C.L. and L.M.) who then discussed and compared their find-
ings to develop a coding frame. Equal attention was paid to each
data extract to identify initial codes, and codes were organised into
one or several broader interpretive themes to fully capture their
meaning.22 Thematic maps, that are a visual representation of the
themes, were used to organise the themes by clustering all codes
according to connections in the data and by considering the patterns
and relationships between themes.22 Additional codes, refinements
to the specifics of themes, and thematic patterns continued until the-
oretical saturation was achieved. Theoretical saturation occurred
when the emergent themes had been fully explored and new data
was easily accommodated within them.22 Themes needed to be pres-
ent in at least two studies to be included in the synthesis, and the
themes were confirmed as being representative of the literature by
a second analyst (L.M.).2.5.2 | Stage 2: exploring relationships between
studies
Vote counting was conducted to identify similarities and differences
between each study, including a subgroup analysis by country, cancer
type, and stage of illness. Thematic vote counting was also conducted
using codes developed in the thematic analysis for this cross case
comparison.21
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The preliminary conceptual framework was sent to an expert
consultation panel to assess the robustness of the synthesis. The
panel comprised 14 advisory committee members of the Living
With and Beyond Cancer Programme (see www.imperial.nhs.uk/
our‐services/cancer‐services/macmillan‐cancer‐partnership/living‐
with‐and‐beyond‐cancer for further details) who had academic,
clinical, or personal expertise about living with and beyond cancer.
They were asked to comment on the general language and use of
an acronym to describe the framework, the positioning of concepts
within different hierarchical levels of the conceptual framework, to
identify any important areas of LWBC which they felt had been
omitted and to make any general observations. The preliminary con-
ceptual framework was modified in response to these comments, to
produce the final conceptual framework.FIGURE 1 Flow chart to show assessment
of eligibility of identified studies2.6 | Ethics approval
The systematic review was conducted as part of a larger study,
funded by Macmillan Cancer Support and hosted by Imperial College
Healthcare NHS Trust. Ethical approval was obtained from the West
Midlands–Black Country Research Ethics Committee and the Health
Research Authority (REC reference 17/WM/0127).
3 | RESULTS
A total of 73 studies focusing on the personal perspective of LWBC
were identified for inclusion in the review. The flow diagram for the
73 included papers is shown in Figure 1 and Data S1 lists those papers
that were included.
The 73 papers described studies conducted in 21 countries, across
multiple cancer types. The sample sizes ranged from four to 156
952 LE BOUTILLIER ET AL.participants with a mean sample size of 20. Data S2 lists the included
study characteristics. The data extraction table provides full partici-
pant and setting details.
3.1 | Quality assessment
The mean quality rating score for the 73 qualitative studies was 10.9
(range 3‐17). A quality rating score of 13 or above, indicating high
quality, was obtained by 25 (34%) papers. A quality rating score of 7
to 12, indicating moderate quality, was obtained by 42 (58%) papers,
and a quality rating score of 0 to 6, indicating low quality, was
obtained by six (8%) papers. The quality ratings of each included study
are reported in the data extraction table (Data S3).
3.2 | Stage 1: developing a preliminary synthesis
Living with and beyond cancer is an experience that disrupts implicit
assumptions about life and forces people to reconstruct their perspec-
tives on self and future.23-38 The disruption of living with and beyond
cancer has been associated with both “relinquishing control”39 and
“taking charge,”40 and while living with and beyond cancer is associ-
ated with loss and altered life,41-48 included studies also report posi-
tive changed attitudes and views of life after a cancer diagnosis.49-57
The thematic analysis of the 73 included studies of conceptualisations
of living with and beyond cancer yielded three interlinked common
themes on how people make sense of their cancer experience: Adver-
sity (realising cancer), Restoration (readjusting life with cancer) and
Compatibility (reconciling cancer), resulting in the overarching ARC
framework. The themes are interlinked because the experience of liv-
ing with and beyond cancer is non‐linear. People affected by cancer
can move backwards and forwards between themes as well as straddle
across themes. Data S4 illustrates the ARC framework. Because of
space limitations, a summary of each theme is provided and the sub-
themes are not elaborated in this article; the full coding framework
is included in Data S5.
3.3 | Theme 1: adversity—realising cancer
The theme “Adversity” refers to the distressing experience of reckon-
ing with the life‐changing impact of a cancer diagnosis, symptoms and
subsequent treatment. In particular, studies identified how the path-
way to cancer diagnosis shaped the personal experience of living with
and beyond cancer. For example, even before diagnosis, some partic-
ipants expressed adversity with health care when they had to persist
to get their symptoms noticed by professionals which delayed diagno-
sis, and for others, when professionals showed a lack of understanding
and symptoms were misdiagnosed:They kept telling me it was thrush and I kept telling them
it wasn't; I said “I have had thrush before; it's not like this.
(Jefferies and Clifford58(p387))Communicating the diagnosis of cancer also had great impact on
the experience. Adversity with healthcare was again experiencedwhen participants were dissatisfied with the clinicians' communication
style:The Surgeon told me on his ward round, he said “you
have got cancer and I'll be back later to explain,” I was
on my own. At the end of the ward round I called the
Consultant back to explain the diagnosis. (France
et al66(p345))
The radiologist who saw the MRI said that the tumour is
big, and there is great damage to the breast. You cannot
imagine the way he told me that … this is not the way to
talk. I left his office so distressed. All I thought about
when I heard his talk is that the cancer is everywhere in
my body, and there is no hope for me. (Obeidat
et al43(p308))Included studies also identify the overwhelming impact of a cancer
diagnosis in terms of adversity experienced because of illness that
included heightened awareness of the body, a challenge to identity
and sense of self, and realisation of mortality. One participant
describes how she will not be a part of the future as she had expected
and hoped:My oldest son got married last summer and I kept
thinking I am never going to be a grandmother. I am
surely going to die soon. I do not want to die.
(Sarenmalm et al59(p1121))Living with the effect of symptoms, that might include managing phys-
ical changes, emotional turmoil, loss of functional independence,
reduced social well‐being, and financial distress, also causes adversity
because of illness:You could not go out and play, and nausea—it's not fun
at all—and you'd like to take that away. But then
there's the headaches, which you can live with, but
some were so great that I just kind of said I do not
want to live anymore. You kind of look at them and try
and stage them, but they are all pretty bad cause if you
look at tiredness, you are laying around and wasting
your day, kind of not fun with those either. (Woodgate
and Degner60(p485))Physical, emotional, and social adversity is also experienced when
managing the consequences of treatment. For example, dealing with
changes in appearance, disrupted everyday roles, or social interac-
tions. Other causes of social adversity include a shift in relationships,
highlighted by concerns of burdening others, social isolation, changes
in intimacy, the impact of providing support for others and, for some,
the impact at work:I do not always tell them (family) how bad things are,
they know it cannot be cured, they know that, but you
know, they'll come and say to me “how are you today?”
“I am alright.” Even if I am not, because I do not like to
worry them. (Harley et al61(p348))
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living with and beyond cancer experience:I do not know what I expected or what sort of care I
expected; not knowing what there is to be offered you
know? Nobody's ever offered anything or said “oh well,
we'll visit you” or anything like that … even if it was a
little phone call to see how you are because you feel
like you are … you have been told, you have been
diagnosed, you are sent home and that's it. What do
you do about it? That's how I felt. I was just thinking
well what do I do about it? Angela. (Reed and
Corner62(p361))Included studies further highlight the adversity experienced
because of healthcare. Some studies describe a “silent” health care
system that provides limited time with healthcare professionals.45,63
Others highlight the feeling of struggling and a loss of control due to
the lack of participants' involvement in treatment planning:Just people bossing you around and telling me what
to do. I know it was for me own good, but people
were just in your face all the time. (Wicks and
Mitchell42(p780))Loss of heath care and social support in the posttreatment phase is
also reported to cause adversity. Oxlad et al found that following com-
pletion of primary treatment, participants described a void, as a result
of a change in the level of healthcare support: “When it's all finished,
it's empty isn't it? There's a void there.”54(p160) The ever‐present fear
of recurrence will also contribute to ongoing stress:I walk around with my nerves on edge, terrified of the
slightest sign of pain, no matter where it might arise.
(Grimsbo et al64(p111))
In your mind, whenever you are having your treatment,
you are thinking, the treatment's keeping the cancer
away. When the treatment stops, you are thinking, well
what's keeping it away, now. (Oxlad et al54(p162))3.4 | Theme 2: restoration—readjusting life with
cancer
The theme “Restoration” refers to the experience of readjusting or
adapting one's life to manage the new context of cancer and recovery.
Factors that were identified as part of the readjustment experience
include confidence in health care, participation in treatment planning,
and lifestyle changes:I also have to play a part. I mean it's a partnership thing
to manage this condition. A patient needs to be able to
be educated to play a part, because not just leave it for
the treatment here, play a part on your diet, play a part
on what you do, play a part in everyday life to see
what you can do to improve things. (Beynon et al65(p173))Existing cancer knowledge and disease experience is another signifi-
cant mediator for coping. For some, knowing that someone else has
been through cancer treatment enables them to see a positive
outcome:You just have to cope, because no one is going to pick you
up. You have to do it… I think possibly because it's just the
knowledge sometimes of knowing that someone else has
been through it and they are fine now. (Fern et al26(pE34))Others draw on available sources of information and support to gain
knowledge on what to expect from treatment:A friend of the wife's [who] had a mastectomy eight
months previous rang, came round to see me and told
me what to expect when I went for the operation.
(France et al66(p346))Alongside access to information and accuracy of information, societal
attitudes and stigma associated with cancer were found to be involved
in the readjustment experience. For example, participants spoke about
managing the challenges of “whispers in public” and about a desire to
be able to appraise illness and talk about cancer openly:People are not able to talk about it … it's this big monster
you are carrying. (Kelly and Dowling45(p40))Appraising illness and values in life were also identified as influenc-
ing the ability to readjust. Boehmke and Dickerson found that those
who approached treatment as a transient experience to be handled
in the short‐term were more able to move on with their lives. One
participant described her illness as “something to get through, and
I know in the end I will be fine.”24(p1124) The importance of social
support and maintaining socially valued roles in restoration is also
highlighted. Types of support identified by participants include rela-
tionships with family and friends and peer support and support
groups:The contact with my family and friends was very
important and helped me not to lose faith. I needed to
talk about it over and over again. (Missel and
Birkelund67[p299])
There are other ladies in the same boat, sometimes we
just sit and talk about it, it's about being in the same
boat is not it? (Davies and Sque68(p589))3.5 | Theme 3: compatibility—reconciling cancer
The theme “Compatibility” refers to that aspect of the experience
that relates to reconciling and rebalancing, creating new priorities
and outlooks. For some participants, cancer is just something else in
life, a contained, concrete medical event without complex
ramifications:I just took it as I would a toothache or whatever it was,
except there was no pain involved. (Foley et al39(p251))
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Cancer is cancer, what the hell? Like I say I am an old
technician and so, if you got a broken piece, you take
the broken piece out and replace it with a good piece.
(Pituskin et al49(p47))And for some, cancer was overshadowed by pre‐existing health
conditions:I certainly wasn't devastated by the fact that I'd got
cancer … I think probably … one of the reasons was
that perhaps the heart was taking precedence over it, in
my mind. (Appleton et al69(p76))Reconciling cancer means that problems assume other proportions
whereby the focus turns to the more positive aspects of life and a shift
in priorities, and that the present and day‐to‐day life are at the centre
of things:I think more about positive things like, really appreciate
day‐to‐day life … and that you appreciate all the small
things more, I think that is definitely true. (Mattsson
et al50(p1006))Trusson et al highlight a broader perspective of well‐being with the
focus on what you have rather than what has been lost.37 Benefit
finding is also found to support the process of reconciling and finding
compatibility between life and cancer. Identified benefits include
improved self‐esteem, better relations and a sense of connection,
and a greater appreciation for life:Going back, I would not change anything. I have often
said that, and people look at you kind of funny. I had
cancer but I would not change it because it's brought
other things forward, it's brought the family closer. We
have learned to deal with things a lot better. You have
to experience what life gives you in order to be able to
move on and be stronger with it. (Pituskin et al49(p48))Kucukkaya found an increased self‐awareness, acceptance of old
and renewed personality and increased appreciation of personal
worth.55 Offering peer support and a willingness to help others is
identified as another support mechanism in the search for compatibil-
ity where people affected by cancer guide others having had a shared
experience:We compare notes, we compare what medicine that we
took, and what is the reaction that we had. So we
empower them and make them understand that they
are not alone in their fight. (de Guzman et al70(p41))3.6 | Stage 2: exploring the relationships between
studies
All 73 studies were included in the vote‐counting process. For each
dominant theme, papers were characterised using subthemesdeveloped from the synthesis. Data S6 shows the vote counting for
the subthemes of each of the three core themes. The “Adversity” sub-
themes present in the most studies were “life‐changing impact of diag-
nosis” (58 studies) and “impact of treatment” (48 studies). The
“Restoration” subthemes most frequently identified were “importance
of social support” (30 studies) and “lifestyle changes” (28 studies). The
most frequent “Compatibility” subthemes were “benefit finding” (15
studies), “offering peer support and willingness to help others,” and
“broader perspectives of well‐being” (both 11 studies each).
Overall, included studies of personal experiences of living with and
beyond cancer made reference to Adversity, Restoration, and/or Com-
patibility. All three ARC themes were identified in 19 of the 73 studies
(26%), with the strongest mapping for “Adversity” (94.5%) and the
weakest mapping for “Compatibility” (34%). Contextual aspects such
as country, study setting, participant (eg, age), or type of cancer did
not produce any apparent differences within the ARC themes. High‐
quality and low‐quality studies did not differ in their profiles. Eleven
of the 25 studies assessed as high quality (scored 13+ out of a possible
18) identified all three themes in the findings.26,31,37,38,53,56,71-75 One
study identified as the lowest quality (scored 6 out of a possible 18)
also highlighted each of the ARC themes.46 Notably, four out of five
studies that explored the lived experience of myeloma identified only
with the concept of Adversity which reflects the nature of the condi-
tion's prognosis. Vote‐counting scores for each theme are included in
Data S2.3.7 | Stage 3: assessing robustness of the synthesis
A response was received from six (43%) of the 14 consulted experts
with academic, clinical, and/or personal expertise of living with and
beyond cancer, who are advisory committee members of the Living
With and Beyond Cancer Programme. Responses were themed under
the following headings: conceptual (dangers of reductionism and limi-
tations of stage models); structural (complete omissions and lack of
emphasis or overemphasis on specific areas of LWBC); and language
(too technical). In response to the experts' comments, the literature
was revisited and the preliminary ARC framework was modified to
have three interrelated rather than staged dominant categories. Some
subcategories were repositioned within themes, and some category
headings changed. Some responses identified areas of omission, such
as the impact of how a cancer diagnosis is first communicated and
the impact of cancer on employment. Alterations were made to
include these as separate subcategories within the thematic analysis.
Overall, the expert consultation process provided an additional validity
check on the content and usefulness of the framework across differ-
ent stakeholder groups in the health system.4 | CONCLUSIONS
Living with and beyond cancer is a concept that is used internationally
in clinical practice and research. Despite this, there is little clarity with
regard to what constitutes living with and beyond cancer from the
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only just becoming established. The aim of the review and narrative
synthesis was to obtain conceptual clarity about the personal experi-
ence of living with and beyond cancer. We identified three interlinked
themes that describe the lived experience of cancer: Adversity, Resto-
ration, and Compatibility, resulting in the ARC framework. The ARC
framework provides an overarching synthesis of how people make
sense of their cancer experience and is leading to a more nuanced
understanding of what it means to live with and beyond cancer. To
our knowledge, this is the first systematic review and narrative syn-
thesis of personal perspectives, and the first empirical identification
of an overarching conceptual framework for LWBC that can be used
as a tool to define and operationalise the term.
The ARC framework complements and aligns constructively with
existing literature on the experience of living with illness.76 For
example, the ARC themes support the themes of biographical disrup-
tion identified by Bury: Adversity matches Coping that refers to
methods used to manage the situation; Restoration matches Strategy
that refers to the way in which people affected by chronic illness act
to deal with it; and Compatibility matches Style that refers to the
notion that different people have different attitudes towards ill-
ness.77 Charmaz, a medical sociologist and ethnographer, also pre-
sents the concept of “loss of self” as a central aspect of the
experience of illness, beyond physical suffering. This refers to losing
valued aspects of one's identity, due to a cascade of physical limita-
tions and social changes.78 This account is mirrored in the “Adver-
sity” and “Restoration” themes, which describe efforts to manage
and contain the impact of diagnosis, symptoms, and treatment on
personal identity, with the responses of one's social and health care
context being a significant influence. Equally, Brennan proposes a
clinically useful conceptual model of psychological adjustment in
cancer, describing a continuous and iterative process of adapting
one's mental models (of self and future etc) when cancer experience
disconfirms one's previous implicit versions.79 The descriptions of a
range of experiences within the “Adversity” theme align closely with
this model. For example, even as people report reactions that are
disparate on the surface (eg, cancer as “a massive shock” yet also
cancer “not taking precedence”), they both derive from the same
underlying process and thus can sit coherently within the same
theme. In addition, the “Compatibility” theme relates to how people
report a novel perspective on life and well‐being, with increased
self‐awareness and changes in priorities, even if experiencing signif-
icant suffering. These experiences align well with the established
concept of post‐traumatic growth, which Tedeschi and Calhoun
describe in their review as “manifesting in a variety of ways, includ-
ing an increased appreciation for life in general, more meaningful
interpersonal relationships, an increased sense of personal strength,
changed priorities, and a richer existential and spiritual life.”80(p1)
Sherman et al also identify the diagnosis of cancer as a turning point
in life, where cancer is recognised as a part of life, leading to the
necessity of learning to live with cancer, and finally, to creating a
new life after cancer.72 Furthermore, these qualitative and concep-
tual accounts are mirrored by quantitative studies of people LWBCthat demonstrate increased psychosocial and interpersonal growth,
despite poorer health and functioning.81 The ARC framework also
extends the concept of post‐traumatic growth because the experi-
ence of living with and beyond cancer is individual and non‐linear,
whereby people affected by cancer can move backwards and for-
wards between the ARC themes as well as straddle across themes.4.1 | Clinical and research implications
The ARC framework challenges more traditional cancer models
because it is built from studies of personal experience. While a
chronic disease model of care82 is widely adopted in the manage-
ment of common chronic illness such as diabetes, depression, and
heart failure (http://www.improvingchroniccare.org), the ARC frame-
work questions the notion of chronicity associated with living with
and beyond cancer and is a useful conceptual framework for trans-
lating the LWBC experience into shaping supportive cancer care.
Like patient pathways that cross organisational boundaries, the
ARC framework can also be used across all levels of the health sys-
tem and in primary and secondary care.83 The ARC framework will
be relevant in informing service design, patient advocacy and
research, with a secondary role in direct clinical practice. The ARC
framework describes the experience of living with and beyond can-
cer in patient‐centred terms, while at the same time aligning closely
with established scientific concepts, models, and evidence. It also
does not view personal experience as a predictable, linear process
related solely to the clinical pathway. Taken together, these qualities
can underpin the design of holistic supportive care services that are
similarly patient‐centred, scientifically valid and non‐linear. For
example, as “Adversity” (the work of realising the impact of cancer)
is experienced and reexperienced and as the biopsychosocial impact
of the illness unfolds, “patient education” needs to be delivered at
multiple touch‐points rather than just clinical starting points. Also,
the ARC framework can express significant aspects of cancer experi-
ence without resorting to unduly medicalising or reductive language.
It can therefore empower patient representatives and advocates
with a tool for promoting patient experience and a structure for its
expression, thus increasing its impact. This may be especially rele-
vant with regard to patient‐centred care, which is often a service
priority but can be clouded by complexities regarding specific clinical
protocols.84 Alongside, the ARC framework provides a foundation
for structuring local guidelines and future policy, benchmarking clin-
ical practice (eg, a basis for developing an accreditation process for
services), and supporting staff development within existing practice
competencies.85 In relation to research, the ARC framework can pro-
vide a core foundational structure as a starting point for investiga-
tion in novel and under‐researched areas, as well as challenging
overly simple research questions. For instance, “Restoration” includes
a significant social support dimension, and thus dyadic‐ or family‐
wide rehabilitation may be more pertinent than more narrowly indi-
vidual self‐management, though much more complex to research.86
Finally, at the level of clinical practice, the ARC framework can
956 LE BOUTILLIER ET AL.provide healthcare staff an evidence‐based tool for interpreting
patients' narratives and guiding them appropriately. For instance,
“Compatibility” highlights how cancer experience is often deeply
transformative, and thus clinicians who hear a patient hoping that
“after treatment everything will settle down and be the same again”
can usefully reframe LWBC as “a new normal” that often involves
both welcome and unwelcome changes. The ARC framework is
informing clinical training in primary care Improving Access to Psy-
chological Therapies services and the secondary care Clinical Nurse
Specialist workforce. An example of ARC use in direct clinical prac-
tice is as a conversation guide for clinicians and patients completing
the recovery package.87 For example, people are supported to iden-
tify interventions and assistance that would enable transition
towards the readjustment and compatibility themes, as well as how
they might be supported to manage any adversity, as part of their
holistic needs assessment.4.2 | Study strengths and limitations
This is the first systematic review and narrative synthesis of personal
perspectives on living with and beyond cancer. Until now, there has
been lack of clarity around what it means to live with and beyond can-
cer. Adopting a transparent systematic review and narrative synthesis
methodology addresses some of the criticisms regarding rigour and
increases confidence in the findings. The robustness of the review
was enhanced by three approaches to validating the framework,
namely, the double rating of a proportion of papers to assess eligibility,
double coding of included papers, and expert consultation on the pre-
liminary framework. The strength of the conceptual framework can
also be assessed on the strength of the evidence; with 67 of the 73
studies being rated as high or medium quality.
Secondly, by adopting broad and inclusive criteria on study context
(eg, service setting and cancer pathway), while checking (using narra-
tive synthesis methodology) that these do not unduly influence the
results, this study allows the emergence of a broader account of
patient experience. Thus, this framework is arguably more person‐
centred and less subject to a priori influences and preconceptions of
clinical parameters, policy priorities, or service realities. As a result, it
can serve better as a solid basis for development in novel or underde-
veloped areas (eg, a novel treatment or the experience of people with
pre‐existing psychosocial vulnerabilities). It can also constructively
challenge more established areas (eg, cancer rehabilitation) to reflect
on whether the practices and solutions that have developed still align
well with core, shared themes of personal experience.
Conversely, a potential limitation is that narrative synthesis is a
secondary analysis of data based on existing interpretations by the
authors of the original papers. As we necessarily accrue inferences
and interpretations with every level of abstraction, there is potential
for subtle or divergent accounts to be overlooked, reducing the rich-
ness of the account or inadvertently silencing some experiences. We
safeguard against this through evaluating primary study quality, cross
validating with clinicians and patients, and ensuring rigour throughoutthe research process. Nevertheless, we recognise that this account
should be viewed as a heuristic framework, rather than as definitive
and nomothetic. Similarly, it is important to note that while individual
real‐world experiences can be accommodated by the ARC framework,
the synthesis of existing studies was at group‐level and individual
accounts go beyond the scope of this study.
A key challenge for health services is the lack of clarity around
what constitutes living with and beyond cancer. The synthesis contrib-
utes to the understanding of living with and beyond cancer, and the
emerging conceptual framework can be used to support clinical prac-
tice by identifying and responding to the needs of the personal expe-
rience of living with and beyond cancer.
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